Chengdu Easton Biopharmaceuticals Co Ltd Capital Reinvestment Ratio
Chengdu Easton Biopharmaceuticals Co Ltd capital reinvestment ratio. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥61.35 Million) in capital expenditures (CN¥24.30 Million). See free cash flow generation of Chengdu Easton Biopharmaceuticals Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Capital reinvestment ratio of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. This chart tracks Chengdu Easton Biopharmaceuticals Co Ltd's Capital Reinvestment Ratio across 13 annual periods. See 688513 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Chengdu Easton Biopharmaceuticals Co Ltd Capital Reinvestment Ratio by Year (2013–2025)
Chengdu Easton Biopharmaceuticals Co Ltd capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see 688513 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥264.94 Million | CN¥86.28 Million | ▼ -27.0% |
| 2024 | 0.45x | CN¥263.24 Million | CN¥117.42 Million | ▼ -29.9% |
| 2023 | 0.64x | CN¥275.25 Million | CN¥175.26 Million | ▼ -71.5% |
| 2022 | 2.23x | CN¥151.94 Million | CN¥339.33 Million | ▲ +28.6% |
| 2021 | 1.74x | CN¥147.60 Million | CN¥256.29 Million | ▲ +36.7% |
| 2020 | 1.27x | CN¥156.52 Million | CN¥198.81 Million | ▲ +88.8% |
| 2019 | 0.67x | CN¥141.83 Million | CN¥95.41 Million | ▲ +46.4% |
| 2018 | 0.46x | CN¥166.79 Million | CN¥76.63 Million | ▲ +71.0% |
| 2017 | 0.27x | CN¥85.70 Million | CN¥23.02 Million | ▲ +59.8% |
| 2016 | 0.17x | CN¥106.06 Million | CN¥17.83 Million | ▼ -76.0% |
| 2015 | 0.70x | CN¥50.57 Million | CN¥35.43 Million | ▲ +48.5% |
| 2014 | 0.47x | CN¥46.71 Million | CN¥22.04 Million | ▼ -82.6% |
| 2013 | 2.71x | CN¥28.12 Million | CN¥76.11 Million | — |